Heart Failure
New England Journal of Medicine Study Shows Dramatically Reducing Pacing to Right Ventricle Cuts Risk of Persistent Atrial Fibrillation in Pacemaker Patients
Published in Physician Business Week, September 18th, 2007
Medtronic, Inc. (NYSE:MDT) announced that reducing right ventricular pacing to less than 10 percent in patients with dual chamber pacemakers reduced the relative risk of developing persistent atrial fibrillation (AF) by 40 percent compared with conventional dual chamber pacing in a trial of more than 1,000 patients with sinus node disease. The trial, called SAVE PACe (The Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction) was funded by Medtronic and is published in this week's The New England Journal of Medicine.
The trial's objective was to demonstrate that dramatically reducing unnecessary right ventricular pacing can reduce...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
More Articles from Physician Business Week
- Biomedicine
Curbing C. difficile’s Toxin Production - Quatech, Inc.
Quatech Ships Initial 802.11a/b/g Wireless Products for Medical Equipment Applications - Radiation Therapy
Leading Hospital in China Selects TomoTherapy's Flexible, Integrated Radiation Therapy Solution - Rehabilitation Research
RehabCare Co-Sponsors Professorship with University of Kansas - Abqaurp
ABQAURP Announces Certificate Course in Medical Error Prevention - Algorithms
Study results from University of Nijmegen provide new insights into algorithms - More from this issue of Physician Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
